JP2005514413A5 - - Google Patents

Download PDF

Info

Publication number
JP2005514413A5
JP2005514413A5 JP2003557583A JP2003557583A JP2005514413A5 JP 2005514413 A5 JP2005514413 A5 JP 2005514413A5 JP 2003557583 A JP2003557583 A JP 2003557583A JP 2003557583 A JP2003557583 A JP 2003557583A JP 2005514413 A5 JP2005514413 A5 JP 2005514413A5
Authority
JP
Japan
Prior art keywords
group
alkoxy
lower alkyl
hydrogen
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003557583A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514413A (ja
JP4610900B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/041481 external-priority patent/WO2003057225A2/en
Publication of JP2005514413A publication Critical patent/JP2005514413A/ja
Publication of JP2005514413A5 publication Critical patent/JP2005514413A5/ja
Application granted granted Critical
Publication of JP4610900B2 publication Critical patent/JP4610900B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003557583A 2001-12-26 2002-12-24 リン酸塩輸送インヒビター Expired - Fee Related JP4610900B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34466001P 2001-12-26 2001-12-26
US37164902P 2002-04-10 2002-04-10
PCT/US2002/041481 WO2003057225A2 (en) 2001-12-26 2002-12-24 Phosphate transport inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010008273A Division JP2010132674A (ja) 2001-12-26 2010-01-18 リン酸塩輸送インヒビター

Publications (3)

Publication Number Publication Date
JP2005514413A JP2005514413A (ja) 2005-05-19
JP2005514413A5 true JP2005514413A5 (enExample) 2010-03-04
JP4610900B2 JP4610900B2 (ja) 2011-01-12

Family

ID=26994039

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003557583A Expired - Fee Related JP4610900B2 (ja) 2001-12-26 2002-12-24 リン酸塩輸送インヒビター
JP2010008273A Withdrawn JP2010132674A (ja) 2001-12-26 2010-01-18 リン酸塩輸送インヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010008273A Withdrawn JP2010132674A (ja) 2001-12-26 2010-01-18 リン酸塩輸送インヒビター

Country Status (7)

Country Link
US (2) US7119120B2 (enExample)
EP (2) EP1815860B1 (enExample)
JP (2) JP4610900B2 (enExample)
AT (2) ATE464905T1 (enExample)
AU (1) AU2002367396A1 (enExample)
DE (2) DE60236117D1 (enExample)
WO (1) WO2003057225A2 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) * 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20060160856A1 (en) * 2002-09-05 2006-07-20 Dahl Bjarne H Diarylurea derivatives and their use as chloride channel blockers
EP1398029A1 (en) * 2002-09-10 2004-03-17 LION Bioscience AG NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives
US7491718B2 (en) * 2002-10-08 2009-02-17 Abbott Laboratories Sulfonamides having antiangiogenic and anticancer activity
WO2004037274A1 (en) * 2002-10-22 2004-05-06 Genzyme Corporation Amine polymers for promoting bone formation
DE10257357A1 (de) 2002-12-09 2004-06-24 Bayer Ag Fluorhaltige Benzaldehyde
EP1753421B1 (en) 2004-04-20 2012-08-01 Amgen Inc. Arylsulfonamides and uses as hydroxysteroid dehydrogenase
CA2583548A1 (en) * 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden
WO2006077901A1 (ja) * 2005-01-20 2006-07-27 Shionogi & Co., Ltd. Ctgf発現阻害剤
WO2007022466A2 (en) * 2005-08-17 2007-02-22 Altairnano, Inc. Hyperphosphatemia in domestic animals: compositions and methods of treatment
JP2009504779A (ja) * 2005-08-17 2009-02-05 アルテアナノ インコーポレイテッド 家畜における慢性腎不全及びその他の病気の治療：組成物及び方法
DE102005044156A1 (de) * 2005-09-15 2007-03-29 Riemser Arzneimittel Ag Substituierte Acetophenonderivate
GB0526252D0 (en) * 2005-12-22 2006-02-01 Novartis Ag Organic compounds
GB0526255D0 (en) * 2005-12-22 2006-02-01 Novartis Ag Organic compounds
JP2009542653A (ja) * 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄（ｉｉ）含有治療剤
WO2009017863A2 (en) 2007-05-08 2009-02-05 Burnham Institute For Medical Research Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
US7776877B2 (en) 2007-06-22 2010-08-17 Chemocentryx, Inc. N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
JP2011523655A (ja) * 2008-06-03 2011-08-18 フレセニウス メディカル ケア ドイッチュランド ゲーエムベーハー ガンマセクレターゼモジュレータを含む医薬組成物
US20110293520A1 (en) 2008-06-09 2011-12-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
CA2729767A1 (en) * 2008-07-07 2010-01-14 Fasgen, Inc. Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same
EP3351248B1 (en) 2008-12-31 2021-06-09 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP3351250A3 (en) 2009-01-26 2018-10-17 Opko Ireland Global Holdings, Ltd. Phosphate management with small molecules
AU2010303270A1 (en) 2009-10-09 2012-05-03 Zafgen Corporation Sulphone compounds for use in the treatment of obesity
ES2561672T3 (es) * 2010-03-05 2016-02-29 Duophos Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal
RU2570007C2 (ru) 2010-05-12 2015-12-10 Спектрум Фармасьютикалз, Инк. Гидроксид карбонат лантана, оксикарбонат лантана и способы их получения и применения
EP2590656B1 (en) 2010-07-07 2017-11-15 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012006473A1 (en) 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012006477A1 (en) 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP2590965B1 (en) * 2010-07-07 2016-04-20 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012012642A1 (en) 2010-07-22 2012-01-26 Zafgen Corporation Tricyclic compounds and methds of making and using same
WO2012103333A1 (en) 2011-01-26 2012-08-02 Zafgen Corporation Tetrazole compounds and methods of making and using same
US9290472B2 (en) 2011-05-06 2016-03-22 Zafgen, Inc. Partially saturated tricyclic compounds and methods of making and using same
BR112013028665A2 (pt) 2011-05-06 2016-09-06 Zafgen Inc compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
CN103764652B (zh) 2011-05-06 2016-03-23 扎夫根股份有限公司 三环吡唑磺酰胺化合物及其制备和使用方法
CA2861390A1 (en) 2012-01-18 2013-07-25 Zafgen, Inc. Tricyclic sulfonamide compounds and methods of making and using same
CA2861381A1 (en) 2012-01-18 2013-07-25 Zafgen, Inc. Tricyclic sulfone compounds and methods of making and using same
CA2880338A1 (en) 2012-08-21 2014-02-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
KR20150080614A (ko) 2012-11-05 2015-07-09 자프겐 인크. 비만의 치료 및/또는 제어에서 사용하기 위한 트리시클릭 화합물
NZ707773A (en) 2012-11-05 2019-05-31 Zafgen Inc Methods of treating liver diseases
MX2015005732A (es) 2012-11-05 2015-12-16 Zafgen Inc Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
KR102287207B1 (ko) 2013-04-12 2021-08-09 알데릭스, 인코포레이티드 Nhe3-결합 화합물 및 포스페이트 수송을 저해하는 방법
CN103467452B (zh) * 2013-09-11 2015-11-18 陕西理工学院 一种苯甲酰胺类化合物及其应用
CN106008360B (zh) * 2016-08-11 2018-10-16 华南农业大学 一种对氨基苯磺酰咪唑及其制备方法
JOP20190080A1 (ar) 2016-10-14 2019-04-11 Bayer Pharma AG مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها
US11046683B2 (en) * 2016-12-15 2021-06-29 Ono Pharmaceutical Co., Ltd. Activator of TREK (TWIK RElated K+ channels) channels
CN110267944B (zh) 2017-01-09 2024-03-08 阿德利克斯股份有限公司 可用于治疗胃肠道病症的化合物
JP2020505333A (ja) 2017-01-09 2020-02-20 アルデリックス， インコーポレイテッド Ｎｈｅ媒介性アンチポートの阻害薬
WO2019028343A1 (en) * 2017-08-03 2019-02-07 Georgetown University SMALL MOLECULE INHIBITORS OF SLC25A1
BR112020014561A2 (pt) 2018-01-17 2020-12-08 Migal - Galilee Research Institute Ltd. Nibidores inovadores da via metabólica da metionina
WO2019142192A1 (en) 2018-01-17 2019-07-25 Gavish-Galilee Bio Applications Ltd. New methionine metabolic pathway inhibitors
CN110305045A (zh) * 2018-03-20 2019-10-08 成都海创药业有限公司 一种酰胺类化合物及其在治疗癌症中的用途
EP3802514B1 (en) 2018-06-01 2022-08-03 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes
CA3133803A1 (en) 2019-04-11 2020-10-15 Angion Biomedica Corp. Solid forms of (e)-3-[2-(2-thienyl)vinyl]-1h-pyrazole
WO2021041561A2 (en) * 2019-08-26 2021-03-04 Avantaggiati Mauria Laura Treating non-alcoholic fatty liver disease and inflammatory steatohepatitis with slc25a1 inhibitors
US20250302833A1 (en) * 2022-05-11 2025-10-02 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for treating or preventing cystic disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652868B1 (en) * 1992-07-28 2004-11-10 Aventis Pharma Limited INHIBITORS OF c-AMP PHOSPHODIESTERASE
EP0619116A3 (en) * 1993-04-05 1994-11-23 Hoechst Japan Use of synthetic retinoids for osteopathy.
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
HUT74450A (en) * 1993-12-27 1996-12-30 Eisai Co Ltd Anthranilic acid derivative and pharmaceutical compns. contg. such compds.
WO1997015308A1 (en) * 1995-10-23 1997-05-01 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
TW523506B (en) * 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
JP2001513503A (ja) * 1997-08-06 2001-09-04 スミスクライン・ビーチャム・コーポレイション 心臓血管系の疾病の治療に用いられるマクロファージスカベンジャー受容体アンタゴニスト
HUP0102782A3 (en) * 1998-06-19 2002-12-28 Smithkline Beecham Corp Salycilanilide as inhibitors of transcription factor nf-kb
JP3972163B2 (ja) * 1999-06-18 2007-09-05 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
AR030911A1 (es) 1999-07-20 2003-09-03 Smithkline Beecham Corp Uso de n-aril-2-sulfonamidobenzamidas para la manufactura de un medicamento para el tratamiento de la insuficiencia renal cronica y composiciones farmaceuticas
AU2001259354A1 (en) 2000-05-02 2001-11-12 Smith Kline Beecham Corporation Phosphate transport inhibitors
JP2003533477A (ja) 2000-05-12 2003-11-11 スミスクライン・ビーチャム・コーポレイション リン酸輸送阻害剤
AU2002213048A1 (en) * 2000-10-05 2002-04-15 Smith Kline Beecham Corporation Phosphate transport inhibitors
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors

Similar Documents

Publication Publication Date Title
JP2005514413A5 (enExample)
JP2012526838A5 (enExample)
CA2495060A1 (en) Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications
JP2010527373A5 (enExample)
RU2001120016A (ru) Ароматические гетероциклические соединения, обладающие активностью в отношении ВИЧ-интегразы
CN103319464A (zh) 病毒聚合酶抑制剂
RU2004121898A (ru) Производные халкона и их применение для лечения заболеваний
MY145408A (en) Dihydropyrazolopyrimidinone derivatives
KR960704884A (ko) 항종양제 또는 항바이러스제로서의 디스타마이신 A 동족체 (Distamycin A analogues as antitumour or antiviral agents)
HU184145B (en) Process for preparing cef-3-em-4-carboxylic acid derivatives
RU2016122908A (ru) Соединения дигидропиримидина и их применение в фармацевтических препаратах
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
JP2005514398A5 (enExample)
JP2007524707A5 (enExample)
JP2005535731A5 (enExample)
CA2850779A1 (en) Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication
KR880005093A (ko) 5-알킬벤즈이미다졸, 그의 제조방법 및 이들을 함유하는 약제학적 조성물
DE2710282A1 (de) 3,7-disubstituierte-3-cephem-4- carbonsaeureverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
CA2728098A1 (en) Pyrazole-containing tricyclic compounds as_antagonits of an ep1 receptor
KR930006008A (ko) N-치환 헤테로고리 유도체, 이의 제조방법 및 이를 함유하는 약화 조성물
DE2824559A1 (de) 7 alpha -methoxy-7 beta-(1,3- dithietan-2-carboxamido)cephalosporansaeurederivate und verfahren zu ihrer herstellung
WO2022115384A1 (en) Tricyclic compounds
CA2634005A1 (en) N-hydroxyamide derivatives possessing antibacterial activity
JP2009520695A5 (enExample)
CA2643005A1 (en) Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof